FDA Releases Guidance to Promote Nonopioid Alternatives for Chronic Pain
2025-09-10
New guidance aims to increase nonopioid choices for chronic pain while combating misuseContinue Reading
WHO Updates List of Essential Medicines to Include GLP-1s
2025-09-09
PD-1/PD-L1 immunotherapies for several metastatic cancers also made the list of essential drugsContinue Reading
Medicaid Crucial In Battling Opioid Epidemic
2025-09-09
TUESDAY, Sept. 9, 2025 (HealthDay News) — Medicaid serves a key role in helping opioid addicts get the treatment they need, a new study says. Prescription rates for the anti-opioid medication buprenorphine increased more than 27% in states that expanded Medicaid between 2018 and 2024, researchers reported in the SeptemberContinue Reading
FDA Expands Use of Vonvendi for Von Willebrand Disease
2025-09-08
The recombinant treatment is now approved for prophylactic use in adults and for treating bleeding episodes and perioperative use in childrenContinue Reading
Substance Use During Pregnancy Can Harm a Fetus, Experts Warn
2025-09-07
SUNDAY, Sept. 7, 2025 (HealthDay News) — Using alcohol, tobacco, marijuana or other substances during pregnancy can harm the developing fetus, even when the risks are not always obvious, a West Virginia University psychiatrist warns. “Many substances can harm a fetus, including substances many falsely perceive to be harmless, likeContinue Reading
FDA Creates ‘Green List’ of GLP-1 Drug Ingredients Approved for Entry in the U.S.
2025-09-05
The purpose of the list is to keep unverified and unapproved GLP-1 drug ingredients from entering the countryContinue Reading
LSD May Ease Anxiety Symptoms for Months, Study Finds
2025-09-05
FRIDAY, Sept. 5, 2025 (HealthDay News) — A single dose of LSD eased anxiety symptoms for many folks and the benefits lasted up to three months, a new study reports. The findings were published Sept. 4 in the Journal of the American Medical Association. Researchers tested several doses of LSDContinue Reading
West Coast Governors Form Health Alliance to Guide Immunization Recommendations
2025-09-04
Governors of California, Oregon, and Washington announced the alliance in response to recent leadership changes and other actions they say have ‘undermined’ the CDCContinue Reading
Florida Plans To End All Vaccine Mandates
2025-09-04
THURSDAY, Sept. 4, 2025 (HealthDay News) — Florida may soon become the first state in the U.S. to eliminate all vaccine mandates, a major shift in health policy that may increase risk of disease outbreaks. The plan was announced this week by State Surgeon General Dr. Joseph Ladapo, who describedContinue Reading
Single-Dose Penicillin Effective Against Early Syphilis
2025-09-04
THURSDAY, Sept. 4, 2025 (HealthDay News) — A single dose of penicillin works just as well to cure early syphilis as the three-injection regimen now used by many doctors, a new clinical trial says. Second and third doses of benzathine penicillin G (BPG) don’t provide any additional benefit in treatingContinue Reading
One Dose of RSV Vaccine May Shield Older People for Two Seasons
2025-09-03
WEDNESDAY, Sept. 3, 2025 (HealthDay News) — A single dose of RSV vaccine might protect seniors for two cold and flu seasons in a row, a new study says. Vaccination reduced seniors’ risk of hospitalization by 58% during two RSV seasons, researchers reported Aug. 30 in the Journal of theContinue Reading
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
2025-09-02
Leqembi Iqlik allows for at-home maintenance dosing after initial 18 months of intravenous dosingContinue Reading
CVS, Walgreens Limit COVID Vaccines in Some States as Rules Shift
2025-09-02
TUESDAY, Sept. 2, 2025 (HealthDay News) — CVS and Walgreens are changing where and how they offer COVID-19 vaccines this season as they work to comply with state laws and current U.S. Centers for Disease Control and Prevention (CDC) guidelines. Both pharmacy chains say vaccine access will now vary byContinue Reading
FDA Now Providing Daily Updates on Adverse Events
2025-08-29
To increase transparency, the agency is publishing data from the FDA Adverse Event Reporting System daily rather than quarterlyContinue Reading